Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FDA approves J&J's autoimmune drug Stelara for Crohn's disease
Tuesday, September 27, 2016Johnson Johnson said on Monday that the US Food and Drug Administration approved the companys blockbuster psoriasis drug Stelara for use in adults with Crohns disease The drug is approved in the United States to treat the skin condition scaly plaqu...
Cerecor Announces Acquisition of TARP-γ8-AMPA Receptor Antagonist (CERC-611) from Lilly
Tuesday, September 27, 2016Cerecor Inc a clinicalstage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders today announced that it has acquired exclusive worldwide rights from Eli Lilly and C...
Ildong Pharma to launch new Hepatitis B drug next year
Monday, September 26, 2016Ildong Pharmaceuticals Hepatitis B treatment Besifovir is in the process of receiving the Ministry of Food and Drug Safetys approval for sales according to industry sources on Sept It will be the first new drug to be developed by the South Korea ph...
Marksans Pharma gets USFDA clearance for allergy drug
Monday, September 26, 2016Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules used for treatment of allergies in the American market In a BSE filing today Marksans Pharma said USFDA has granted approval for an abbreviated...
Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
Monday, September 26, 2016Regeneron Pharmaceuticals Inc and Sanofi today announced that the US Food and Drug Administration FDA has accepted for priority review the Biologics License Application BLA for dupilumab for the treatment of adult patients with inadequately controlle...
Novartis's Zykadia gets positive results, faces Roche pressure
Saturday, September 24, 2016Novartiss Zykadia drug performed well against a rare form of lung cancer the Swiss company said on Friday citing a study it hopes will help it win expanded regulatory approval for the use of the drug But it faces competition from a medicine produced...
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Saturday, September 24, 2016The US Food and Drug Administration on Friday approved Amgen Incs biosimilar version of AbbVies topselling arthritis drug Humira The drug Amjevita known also as adalimumabatto was approved to treat rheumatoid arthritis psoriatic arthritis Crohns dis...
Vanda Pharmaceuticals prepares to explore a sale
Friday, September 23, 2016Vanda Pharmaceuticals Inc VNDAO a US developer of medicines for the central nervous system is preparing to consider strategic alternatives including a potential sale according to people familiar with the matter The move illustrates how Vanda is seek...
U.S. states sue opioid-maker Indivior, alleging anticompetitive practices
Friday, September 23, 2016Thirtyfive US states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market Britishbased Indivior which was spun off from Reckitt Benckiser in...
Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd.
Friday, September 23, 2016Biostar Pharmaceuticals Inc a PRCbased manufacturer of pharmaceutical and health supplement products and Xianyang Yongsheng Health Products Co Ltd a privately held PRCbased health product manufacturer located in Xianyang China Xianyang Yongsheng anno...
